Canada and Europe Finalize Trade Deal Text Confirming New IP Provisions on Pharmaceuticals

Drug Industry Daily
European and Canadian trade negotiators reportedly have finalized the text of an historic deal that will bring Canada’s intellectual property regulations for pharmaceuticals closer to those of the EU, although it may take another two years before the agreement is actually implemented.

To View This Article:


Subscribe To Drug Industry Daily